Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Operating Leases (2019 - 2025)

Cumberland Pharmaceuticals (CPIX) has disclosed Operating Leases for 7 consecutive years, with $4.9 million as the latest value for Q4 2025.

  • Quarterly Operating Leases fell 6.73% to $4.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.9 million through Dec 2025, down 6.73% year-over-year, with the annual reading at $4.9 million for FY2025, 6.73% down from the prior year.
  • Operating Leases hit $4.9 million in Q4 2025 for Cumberland Pharmaceuticals, down from $5.0 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $5.6 million in Q4 2023 to a low of $90016.0 in Q4 2021.
  • Historically, Operating Leases has averaged $3.6 million across 5 years, with a median of $4.8 million in 2025.
  • Biggest five-year swings in Operating Leases: tumbled 95.66% in 2021 and later soared 4994.98% in 2022.
  • Year by year, Operating Leases stood at $90016.0 in 2021, then skyrocketed by 4994.98% to $4.6 million in 2022, then rose by 23.07% to $5.6 million in 2023, then decreased by 6.17% to $5.3 million in 2024, then fell by 6.73% to $4.9 million in 2025.
  • Business Quant data shows Operating Leases for CPIX at $4.9 million in Q4 2025, $5.0 million in Q3 2025, and $4.7 million in Q2 2025.